Gonococcal susceptibility to cephalosporins - Hawaii, 2003 to 2011

Sexually Transmitted Diseases

Volumn 40, Issue 9, 2013, Pages 756-759

  Kidd, Sarah ^a   Lee, Maria V C ^b   Maningas, Eloisa ^b   Komeya, Alan ^b   Kunimoto, Gail ^b   O'Connor, Norman ^b   Katz, Alan R ^b,c   Wasserman, Glenn M ^b   Kirkcaldy, Robert D ^a   Whelen, A Christian ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HAWAII STATE DEPARTMENT OF HEALTH   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFPODOXIME; CEFTRIAXONE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GONORRHEA; HUMAN; INFECTION SENSITIVITY; MEN WHO HAVE SEX WITH MEN; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; PROSTITUTION; SEXUAL INTERCOURSE; SOLDIER; UNITED STATES;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CEFIXIME; CEFTIZOXIME; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HAWAII; HETEROSEXUALITY; HOMOSEXUALITY, MALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; POPULATION SURVEILLANCE; PREVALENCE; YOUNG ADULT;

EID: 84883262795     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/01.olq.0000431357.18959.30     Document Type: Article

References (11)

1. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: Are cephalosporins next? Curr Infect Dis Rep 2011; 13:196-204.
2. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer recommended for treatment of gonococcal infections. MMWR 2012; 61:590-594.
3. Ito M, Yasuda M, Yokoi S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48:3185-3187.
4. Tanaka M, Nakayama H, Tunoe H, et al. A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan. J Infect Chemother 2002; 8:81-86.
5. European Centre for Disease Prevention and Control. Gonococcal Antimicrobial Susceptibility Surveillance in EuropeV2010. Stockholm: ECDC, 2012.
6. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones are no longer recommended for treatment of gonococcal infections. MMWR 2007; 56:332-336.
7. Perine P, Morton R, Piot P, et al. Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae. Sex Transm Dis 1979; 6:152-158.
8. Jaffe H, Biddle J, Johnson S, et al. Infections due to pneicillinaseproducing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis 1981; 144:191-197.
9. Wang SA, Lee MV, O'Connor N, et al. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefiximeVHawaii, 2001. Clin Infect Dis 2003; 37:849-852.
10. Centers for Disease Control and Prevention. Follow-up on penicillinaseproducing Neisseria gonorrhoeaeVworldwide. MMWR 1977; 26: 153-154.
11. Katz AR, Komeya AY, Soge OO, et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: Case report of the first isolate identified in the United States. Clin Infect Dis 2012; 54:841-843.